Dianthus Therapeutics, Inc.DNTHNASDAQ
LOADING
|||
Switch Symbol:
Net Income Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year net income growth rate
Latest
-16.24%
↓ 31% below average
Average (34q)
-12.37%
Historical baseline
Range
High:56.05%
Low:-226.98%
Volatility
-2288.5%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | -16.24% |
| Q2 2025 | -7.18% |
| Q1 2025 | -3.77% |
| Q4 2024 | -12.97% |
| Q3 2024 | -42.98% |
| Q2 2024 | -28.07% |
| Q1 2024 | -30.15% |
| Q4 2023 | 28.45% |
| Q3 2023 | -32.52% |
| Q2 2023 | -57.14% |
| Q1 2023 | 29.92% |
| Q4 2022 | -29.96% |
| Q3 2022 | 54.93% |
| Q2 2022 | 24.75% |
| Q1 2022 | -18.96% |
| Q4 2021 | -10.70% |
| Q3 2021 | -2.95% |
| Q2 2021 | 3.21% |
| Q1 2021 | 3.74% |
| Q4 2020 | -2.77% |
| Q3 2020 | 7.34% |
| Q2 2020 | 4.66% |
| Q1 2020 | 13.88% |
| Q4 2019 | -10.71% |
| Q3 2019 | -18.53% |
| Q2 2019 | -19.37% |
| Q1 2019 | 11.06% |
| Q4 2018 | -4.15% |
| Q3 2018 | -17.24% |
| Q2 2018 | -22.39% |
| Q1 2018 | -38.89% |
| Q4 2017 | -16.24% |
| Q3 2017 | 56.05% |
| Q2 2017 | -226.98% |
| Q1 2017 | 0.00% |